XML 63 R42.htm IDEA: XBRL DOCUMENT v3.24.2.u1
ACQUISITIONS - Narrative (Details) - Spectrum Pharmaceuticals, Inc.
$ / shares in Units, $ in Millions
3 Months Ended 6 Months Ended
Jul. 31, 2023
USD ($)
$ / shares
Jun. 30, 2024
USD ($)
Jun. 30, 2023
USD ($)
Jun. 30, 2024
USD ($)
Jun. 30, 2023
USD ($)
Dec. 31, 2025
USD ($)
$ / shares
Dec. 31, 2024
USD ($)
$ / shares
Business Acquisition [Line Items]              
Business acquisition, fixed exchange ratio 0.1783            
Business acquisition, contingent consideration, per share, maximum (in dollars per share) | $ / shares $ 0.20            
Acquired finite-lived intangible assets, useful life 10 years            
Acquisition costs related to the transaction   $ 0.0 $ 3.4 $ 0.0 $ 5.8    
ROLVEDON              
Business Acquisition [Line Items]              
Business combination, contingent consideration arrangements, range of outcomes, value, high $ 44.7            
ROLVEDON | Forecast              
Business Acquisition [Line Items]              
Business acquisition, contingent consideration, per share, maximum (in dollars per share) | $ / shares           $ 0.10 $ 0.10
Business combination, contingent consideration arrangements, range of outcomes, value, high           $ 225.0 $ 175.0